Quantcast

Latest Kapil Dhingra Stories

2014-04-29 12:32:37

SAINT-GENIS-POUILLY, France, April 29, 2014 /PRNewswire/ -- Advanced Accelerator Applications S.A. ("AAA" or "the Company"), an international specialist in Molecular Nuclear Medicine, today announced that Dr Kapil Dhingra has joined the Company Board of Directors as an Independent Non-Executive Director. Stefano Buono, Chief Executive Officer of AAA, commented: "Dr. Dhingra's guidance and perspective on clinical development, regulatory and commercial strategy will be...

2009-02-23 06:00:00

BETHESDA, Md., Feb. 23 /PRNewswire/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that Dr. Kapil Dhingra has joined its Board of Directors, effective as of February 18, 2009. As a result of Dr. Dhingra's appointment, the Board is now comprised of nine members. Dr. Dhingra has been active in oncology clinical research for over 20 years. During his tenure...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related